Syros Pharmaceuticals, Inc is a biotechnology business based in the US. Syros Pharmaceuticals shares (SYRS) are listed on the NASDAQ and all prices are listed in US Dollars. Syros Pharmaceuticals employs 103 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Syros Pharmaceuticals
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – SYRS – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Syros Pharmaceuticals stock price (NASDAQ: SYRS)Use our graph to track the performance of SYRS stocks over time.
Syros Pharmaceuticals shares at a glance
|Latest market close||$6.30|
|52-week range||$4.43 - $15.65|
|50-day moving average||$5.44|
|200-day moving average||$7.81|
|Wall St. target price||$16.57|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.95|
Buy Syros Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Syros Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Syros Pharmaceuticals price performance over time
|1 week (2021-07-17)||N/A|
|1 month (2021-06-28)||15.17%|
|3 months (2021-04-28)||-2.33%|
|6 months (2021-01-24)||N/A|
|1 year (2020-07-24)||N/A|
|2 years (2019-07-24)||N/A|
|3 years (2018-07-24)||N/A|
|5 years (2016-07-24)||N/A|
Syros Pharmaceuticals financials
|Revenue TTM||$17.5 million|
|Gross profit TTM||$15.1 million|
|Return on assets TTM||-25.44%|
|Return on equity TTM||-71.58%|
|Market capitalisation||$311.1 million|
TTM: trailing 12 months
Shorting Syros Pharmaceuticals shares
There are currently 4.8 million Syros Pharmaceuticals shares held short by investors – that's known as Syros Pharmaceuticals's "short interest". This figure is 2.4% down from 4.9 million last month.
There are a few different ways that this level of interest in shorting Syros Pharmaceuticals shares can be evaluated.
Syros Pharmaceuticals's "short interest ratio" (SIR)
Syros Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Syros Pharmaceuticals shares currently shorted divided by the average quantity of Syros Pharmaceuticals shares traded daily (recently around 1.4 million). Syros Pharmaceuticals's SIR currently stands at 3.43. In other words for every 100,000 Syros Pharmaceuticals shares traded daily on the market, roughly 3430 shares are currently held short.
However Syros Pharmaceuticals's short interest can also be evaluated against the total number of Syros Pharmaceuticals shares, or, against the total number of tradable Syros Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Syros Pharmaceuticals's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Syros Pharmaceuticals shares in existence, roughly 80 shares are currently held short) or 0.0927% of the tradable shares (for every 100,000 tradable Syros Pharmaceuticals shares, roughly 93 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Syros Pharmaceuticals.
Find out more about how you can short Syros Pharmaceuticals stock.
Syros Pharmaceuticals share dividends
We're not expecting Syros Pharmaceuticals to pay a dividend over the next 12 months.
Syros Pharmaceuticals share price volatility
Over the last 12 months, Syros Pharmaceuticals's shares have ranged in value from as little as $4.43 up to $15.65. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Syros Pharmaceuticals's is 1.7824. This would suggest that Syros Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Syros Pharmaceuticals overview
Syros Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are SY-1425, a selective retinoic acid receptor alpha agonist, which is in Phase II clinical trial for genomically defined subset of patients with acute myeloid leukemia and phase III clinical trial for patents with myelodysplastic syndrome; SY-5609, a cyclin-dependent kinase 7 inhibitor, which is in a Phase I clinical trial in patients with select advanced solid tumors; and SY-2101, a novel oral form of arsenic trioxide for treating patients with acute promyelocytic leukemia. It has target discovery, research collaboration, and option agreement with Incyte Corporation to identify therapeutic targets with a focus on myeloproliferative neoplasms; and a license agreement with TMRC Co. Ltd. for the development and commercialization of tamibarotene. The company was formerly known as LS22, Inc.
Stocks similar to Syros Pharmaceuticals
Syros Pharmaceuticals in the news
Stocks That Hit 52-Week Lows On Tuesday
Were Hedge Funds Right About Syros Pharmaceuticals, Inc. (SYRS)?
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study
Frequently asked questionsWhat percentage of Syros Pharmaceuticals is owned by insiders or institutions?
Currently 4.948% of Syros Pharmaceuticals shares are held by insiders and 99.103% by institutions. How many people work for Syros Pharmaceuticals?
Latest data suggests 103 work at Syros Pharmaceuticals. When does the fiscal year end for Syros Pharmaceuticals?
Syros Pharmaceuticals's fiscal year ends in December. Where is Syros Pharmaceuticals based?
Syros Pharmaceuticals's address is: 35 CambridgePark Drive, Cambridge, MA, United States, 02140 What is Syros Pharmaceuticals's ISIN number?
Syros Pharmaceuticals's international securities identification number is: US87184Q1076 What is Syros Pharmaceuticals's CUSIP number?
Syros Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 87184Q107
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy HNC Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert